
IndraLab
Statements
sparser
"The most likely antiproliferative mechanism of metformin was reportedly associated with its ability to activate AMPK and LKB1, which inhibits the mechanistic target of rapamycin (mTOR) (a commonly dysregulated pathway in cancer) and consequently inhibit protein synthesis and cell proliferation [ xref ]."
reach
"Hence, a substantial decrease in circZNF559 expression in CPT-derived P-SSCs may contribute to the development of the tibia, offering a possible approach for treating CPT.Osteosarcoma is caused by the deletion of liver kinase b1 (Lkb1) via Ctsk-Cre, which activates mammalian target of rapamycin complex 1 (mTORC1) [75] (Fig. 3D and Table 3)."
reach
"SIRT3 can increase the deacetylation level and activity of LKB1 (Woods et al. 2003), which in turn promotes the phosphorylation level and activity of AMP activated protein kinase (AMPK) (Pillai et al. 2010) and inhibits the activity of mTOR, thereby promoting autophagy (Jung et al. 2010)."
reach
"Interestingly, the smallest impact on metabolism was seen in NCI-H1568 and NCI-H1944 that are both STK11-inactivated, which results in decreased AMPK activation and increased mTOR signaling, potentially protecting the cells from this effect of tipifarnib.The observed altered metabolism can also be linked to ferroptosis, a form of regulated cell death caused by peroxidation of lipids due to high levels of ROS and intracellular iron."
reach
"Pathogenic mutations of STK11/LKB1 lead to inactivation of its expression product and loss of inhibition of mammalian target of rapamycin (mTOR) activity, which leads to abnormal activation of the LKB1/mTOR signal pathway and the occurrence of black spots on the skin and gastrointestinal hamartoma polyps[5]."
reach
"The mTOR signaling is negatively regulated by LKB1 (liver kinase B1) and its downstream target AMP activated protein kinase (AMPK), two master nutrient sensors, that sense cellular stress (e.g., limiting ATP levels) and promote FAO in CD8 T cell memory and Treg cells (XREF_FIG) [XREF_BIBR], [XREF_BIBR]."
reach
"STK11 also negatively regulates mammalian target of rapamycin (mTOR) signaling through its substrate AMPK, and the loss of STK11 leads to the aberrant activation of mTOR in a variety of tissues, with a case study showing usefulness of the mTor inhibitor everolimus for therapy (5-6) (Figure 1)."
reach
"In contrast, tumor suppressor proteins such as PTEN, AMPK, STK11 and LKB1 and TSC1/2, can negatively regulate MTOR and enhance autophagy.60 Studies have identified aberrant ATG genes and ATG protein expression profiles in OSCC tissues or cell lines, including LC3, BECN1, ATG16L1, LC3, BECN1, ATG9A, SQSTM1 and ATG5.15,16,21,22,25-28 Recent data on the autophagic activity in OSCCs are summarized in Table 1."
reach
"While the inhibition of mTOR activity as well as activation by the tumor suppressor LKB1 serve as a basis for AMPK 's anti-tumor effects, induction of potentially pro survival pathways like autophagy and glucose uptake have been proposed to challenge the molecule 's anti-cancer role [XREF_BIBR]."
reach
"Melanocytic nevi, a benign proliferation of melanocytes, which can give birth to malignant melanoma, show in many cases elevated PLD2 expression as well as activation of Akt, whereas LKB1 expression is still high in most cases, suppressing aberrant mTOR activation, which occurred only in 25% of the analysed specimen (XREF_FIG)."
reach
"It is thought that MET in culture conditions with high concentrations of glucose stimulates AMPK through an LKB1-dependent mechanism, which blocks mTOR, causing a powerful inhibition of cell proliferation in several types of cancer cells specially non-TN breast cancer cells (21, 25, 26)."
reach
"Second, in HeLa and pMEP4-LKB 1 inducible cells, induction of LKB1 decreased the activation of mTOR (phospho-mTOR, XREF_FIG, XREF_SUPPLEMENTARY) while enhancing the activation of AMP activated protein kinase (AMPK) as reflected by an increase in the phosphorylation of acetyl-CoA carboxylase (ACC), a substrate of the LKB1-AMPK cascade (XREF_FIG)."
reach
"Since the PI3K and Akt and MAPK and ERK signaling pathways, which positively regulate the mTOR axis, are often activated in many types of cancer, and LKB1, which suppresses mTOR signaling, is frequently mutated in certain types of cancers, mTOR signaling is consequently hyper-activated in many types of cancers."